Analyst Ratings for Medpace (MEDP)
MEDP Rating Summary
MEDP Price Target Summary
- Highest: $700.00 (Mizuho)
- Lowest: $485.00 (Leerink)
- Average: $600.82
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$600.82 (-2.9%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
Avg. $ Target:
$600.82 (-2.9%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2026 | UBS | Kevin Caliendo | New Coverage | Neutral (N/A) |
673.00 (N/A) |
615.94 (618.47) |
0.41% | Details |
| 7/8/2026 | Baird » Updated 9/29/2026 |
Eric Coldwell | Downgrade | Neutral (Outperform) |
638.00 (624.00) |
565.09 (618.47) |
9.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
